So it's that simple? No one bothered or had the funding to try? You'd think given how profitable success would have been that one of the big pharma companies would have trialled it to some degree in humans. Oh well, there loss is our gain.
By the way, I can't believe we are still under CR price. I know it was a big CR but the news should of successful phase 2b trials should of pushed us to around 500m cap imo. So even if you take into account the new CR shares we should be around 2.50 a share the way I see it.
Hopefully there is bit of news about the RRV and U.S. defence department partnership and possible revenue from this deal to show the possibilities to the market.
PAR's UP!, page-24
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.030(10.9%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 24.0¢ | $429.9K | 1.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161991 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29634 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.030 ( 7.51 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.0¢ | 23.5¢ | 433775 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| PAR (ASX) Chart |